IQVIqvia Holdings INC.

Quotes delayed by up to 15 minutes · informational, not investment advice

Escopo e origem dos dados

Ativo: IQV
Moeda das demonstrações: USD
Último período anual nesta tabela: 2025-12-31
Fonte das demonstrações: SEC EDGAR

Data de demonstração não é horário de cotação. Dado ausente não é zero. A cobertura varia por ativo e fonte; confira o documento original antes de interpretar um número.

Fontes e metodologia

About the company

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisio…

IndustryMedical - Diagnostics & Research

Official website →

Smart calendar

Organizing upcoming events...

Key metrics

What the market pays

P/E

Price divided by trailing 12-month earnings

32.77×

P/B

Price divided by book value

7.22×

EV/EBITDA

Enterprise value divided by operating cash generation

16.49×

EV/Revenue

Enterprise value divided by revenue

3.43×

What the company earns

ROE

Return on shareholders’ equity

22%

ROA

Return on all assets

4.6%

Gross margin

What remains after product costs

26.2%

Operating margin

What remains after operating the business

13.6%

Net margin

How much of each revenue unit becomes profit

8.1%

What it owes

Debt / Equity

Debt for each unit of shareholders’ equity

2.63

Total debt

Sum of borrowings

$16.24B

Cash

Cash available to cover it

$1.91B

Current ratio

Short-term assets divided by short-term liabilities

0.71

Free cash flow

Cash left after investing

$360M

Risk and growth

Beta

Moves more (>1) or less (<1) than the market

1.19

Revenue growth

Compared with the same period a year earlier

8.7%

Earnings growth

Compared with the same period a year earlier

-3.8%

Dividend yield

Trailing 12-month distributions divided by price

Market data provider figures for the latest published period. Informational, not investment advice.

Financial statements(USD)

Income statement

	2022	2023	2024	2025
Receita	14.41B	14.98B	15.41B	16.31B
Despesas com vendas e administrativas	-2.07B	-2.05B	-1.99B	-2B
Resultado operacional	1.8B	1.98B	2.2B	2.18B
Despesa financeira	-416M

News about IQV

Yahoo Finance · 6 days ago

	2022	2023	2024	2025
Ativo total	25.34B	26.68B	26.9B	29.94B
Ativo circulante	4.98B	5.6B	5.83B	6.25B
Caixa e equivalentes	1.22B	1.38B	1.7B	1.98B
Contas a receber	2.92B	3.38B	3.2B	3.4B
Imobilizado	532M	523M	535M	533M
Passivo total	19.57B	20.57B	20.83B	23.31B
Passivo circulante	5.58B	6.49B	6.96B	8.34B
Dívida de longo prazo	12.6B	12.96B	12.84B	13.88B
Patrimônio líquido	5.77B	6.11B	6.07B	6.63B

IQVIqvia Holdings INC.

Escopo e origem dos dados

About the company

Smart calendar

Key metrics

What the market pays

What the company earns

What it owes

Risk and growth

Financial statements(USD)

Income statement

News about IQV

A Strong Rebound Case of IQVIA Holdings (IQV)

IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector?

Ações da IQVIA sobem com oferta de dívida principal de US$ 2 bilhões

IQVIA stock rises amid $2 billion senior notes offering

IQVIA prices $2B of senior notes due 2034

Balance sheet